News

NHS green lights ‘Trojan horse’ treatment that attacks cancer cells from inside
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
NHS England7h
NHS first in world to roll out new ‘trojan horse’ therapy for blood cancer patients
The NHS in England will be the first health system in the world to roll-out a ‘trojan horse’ targeted therapy for blood cancer patients which could halt the disease’s progression by nearly three times ...
‘Trojan horse’ treatment given green light for NHS use
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
World-first blood cancer therapy to be given on NHS
A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world first. It can halt the blood cancer myeloma for nearly three times longer ...
The American Journal of Managed Care18h
ADVANCE Trial Supports DKRd as New Standard of Care for Newly Diagnosed Multiple Myeloma: Ola Landgren, MD, PhD
Ola Landgren, MD, PhD, shares ADVANCE trial results, which show that adding daratumumab to carfilzomib-lenalidomide-dexamethasone (DKRd) improves outcomes in newly diagnosed multiple myeloma.